UCSD, U of Manitoba, St. Boniface Hospital Albrechtsen Research Center, WinSanTor deal

Have you been diagnosed with peripheral neuropathy? We can help.

3d rendered medically accurate illustration of the foot nerves

The organizations granted WinSanTor an exclusive license to develop and commercialize small molecule antagonists of muscarinic receptor to treat peripheral neuropathy. The lead compound, WST-057, is in Phase I trials for the indication, with Phase II trials slated for 2017. WinSanTor declined to disclose financial details, and St. Boniface did not respond in time for publication. The universities did not respond to inquiries.

St. Boniface Hospital Albrechtsen Research Center, Winnipeg, Manitoba
University of California San Diego, La Jolla, Calif.
University of Manitoba, Winnipeg, Manitoba
WinSanTor Inc., San Diego, Calif.
Business: Neurology


Your subscription could not be saved. Please try again.
Your subscription has been successful.

Sign up for our newsletter

Free to join.

Your privacy is very important to us. We will never share your information without your written consent.

WinSanTor is based in San Diego, California, USA

Share This Story, Choose Your Platform!

Related Posts

Senior Asian woman sitting in the living room at home and showing body aches, aging sickness, body aches of elderly people.

Understanding Pain: Acute vs. Chronic

Acute pain: a short-term alarm Acute pain is akin to an alarm bell, alerting us immediately to potential harm. It can arise from various causes, including surgery, broken bones, dental

Older man with back pain.

Beyond Pain Management: Breaking From the Past

The importance of understanding inflammation in pain resolution Inflammation is more than a mere symptom of injury or infection. It plays a pivotal role in tissue repair and pain resolution,

Have you been diagnosed with peripheral neuropathy? We can help.